High-dose probiotics for the treatment of active pouchitis.
about
Responders and non-responders to probiotic interventions: how can we improve the odds?Use of Biologics in Pouchitis: A Systematic ReviewThe role of antibiotics and probiotics in pouchitisThe role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trialsProbiotics in inflammatory bowel diseases and associated conditionsHistamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signalingThe human microbiome and probiotics: implications for pediatricsPost-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.Diagnosis and management of postoperative ileal pouch disorders.Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Recommendations for probiotic use in humans-a 2014 updateSafety assessment of probiotics for human use.Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.Gut microbiota and inflammation.Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chrWhat colorectal surgeons should know about probiotics: a review.Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitisEfficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitisProbiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial.Diet of patients after pouch surgery may affect pouch inflammation.Probiotics and diverticular disease.Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome.Intestinal bacteria and the regulation of immune cell homeostasis.Consensus guidelines for the management of inflammatory bowel disease.Use of probiotics in gastrointestinal disorders: what to recommend?The bacterial pathogenesis and treatment of pouchitis.Etiology of pouchitis.Indications for the use of probiotics in gastrointestinal diseases.Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.Role of intestinal bacteria in the pathogenesis of pouchitis.Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches.The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: a randomised controlled trial.
P2860
Q24594332-FA5E066F-F7B7-4FD1-B4AB-CDBEB3D2C6E2Q26995117-CA643CF3-E2B7-4120-9A14-603BF72C67F5Q27000314-797749C6-2A9D-4A1E-83AA-6B12C7395DD2Q27001546-5308BF3A-6AAA-4653-BD66-9F82CF1267BFQ27002496-8C92A555-0EA8-4DB6-B8C7-67054ABDCD41Q28481171-9D466A3E-5E4D-4FC4-8ECA-1A960772DF92Q28750959-6133957D-1792-4011-A032-123635442F91Q33406281-F2BE6F05-5AC7-41D5-8FAE-FE1278958337Q34192292-08B39B84-B089-4B80-9B3C-4B34BB16C215Q34237313-3D568213-1948-4811-A5E2-97F61C63DC3AQ34387493-CEC81DF8-E7A7-4F4F-BEA4-79ED98084919Q34411373-F4ABFA3A-04F2-41BA-8334-93202A77F225Q34503589-8CA5A705-B6D5-4E6B-9BB4-8E52261B1D63Q34801289-A9DDBB3A-6AE4-450D-8D88-2B4D3B35504AQ35245299-625725A5-9C4A-4838-8AEC-9F1E54398BE5Q35601294-BFCF8DD8-A0EA-44FE-867E-7C7EC06D68DAQ35670894-302CEDA4-B22B-4CFA-8F1C-54C3B38D707EQ35693684-40AEDDD3-8B80-4107-90BC-CF90B90B841FQ35770445-F0A84692-2084-4196-92A4-BFA6557474B3Q35801931-A6DD7012-B83A-4762-BE56-8EBEF7BE283AQ35812927-EBA67E28-9E5D-4DA2-B9E6-10AFA4CD54CFQ35832867-D8D57332-51B8-4A4B-9164-686A445FB146Q35942223-3FEAC5A2-4D51-4CBD-8C5C-8817FCC00906Q37118873-72CA1A72-6D2C-4BE4-A553-6E538E670580Q37150557-F260461C-3898-4854-A93F-FBE66679ECBAQ37241528-91C385DD-99A7-4A5E-9DEF-C7CF43318E9AQ37401590-9999CA47-C1D6-4E36-9877-B976EC4FC246Q37682520-0541E71F-573B-42AA-8912-CE551522AA9CQ37700728-D4FED7F6-B08F-4945-B3F8-A3B2CFE98AEAQ37817803-C5E3F881-3BC7-4998-A38E-A5379BBDF2A9Q37823328-17E40702-2BF3-4FFF-A795-9E07227210A8Q37823330-83912011-75ED-473A-A08E-E6F555937DABQ37948714-16C85CB8-74FF-4744-AEA1-3EF0F0493FFBQ37969593-71A4C307-3288-45D4-B874-1C70CD95DD70Q38003046-768B65C9-E4DB-405B-9E39-16B1EAFBD482Q38232120-3910EE15-79A0-42FF-8C2A-4FDC77230667Q38321531-10265C23-2F4D-4A44-8DA2-9F92C13D5581Q38552422-58623FF5-9D8D-4305-A06C-7235AACB4BF7Q38810502-C20F8628-9759-44DE-95D7-F7D3AD2B70A5Q38870885-250DD676-E73A-4881-9B29-EB0F41192FB7
P2860
High-dose probiotics for the treatment of active pouchitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
High-dose probiotics for the treatment of active pouchitis.
@en
High-dose probiotics for the treatment of active pouchitis.
@nl
type
label
High-dose probiotics for the treatment of active pouchitis.
@en
High-dose probiotics for the treatment of active pouchitis.
@nl
prefLabel
High-dose probiotics for the treatment of active pouchitis.
@en
High-dose probiotics for the treatment of active pouchitis.
@nl
P2093
P50
P1476
High-dose probiotics for the treatment of active pouchitis.
@en
P2093
Beatrice Vitali
Claudia Morselli
Gilberto Poggioli
Giulia Straforini
Rosi Tambasco
P2888
P304
2075-82; discussion 2082-4
P356
10.1007/S10350-007-9068-4
P577
2007-10-13T00:00:00Z